Intended management of children with acute idiopathic thrombocytopenic purpura: A national survey

Journal of Paediatrics and Child Health

Volumn 41, Issue 1-2, 2005, Pages 52-55

  Marks, Michael K ^a,b   Vadamalayan, B ^a   Ekert, H ^a,b   South, M J ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Idiopathic; Idiopathic thrombocytopenic purpura management; Purpura; Thrombocytopenic

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; RHESUS D ANTIBODY;

AUSTRALIA; BONE MARROW BIOPSY; CHILDHOOD DISEASE; COMPARATIVE STUDY; CORTICOSTEROID THERAPY; DRUG CHOICE; DRUG DOSE REGIMEN; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOTHERAPY; MEDICAL PRACTICE; MEDICAL SOCIETY; MUCOSAL BLEEDING; NORMAL HUMAN; NORTH AMERICA; PEDIATRICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE COUNT;

ACUTE DISEASE; ADOLESCENT; ADRENAL CORTEX HORMONES; AUSTRALIA; CHILD, PRESCHOOL; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; NORTH AMERICA; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PREDNISOLONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUESTIONNAIRES;

EID: 13544270037     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2005.00536.x     Document Type: Review

References (12)

1. Vesely S, Buchanan GR, Cohen A, Raskob G, George J. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J. Pediatr. Hematol. Oncol. 2000; 22: 55-61.
2. Vesely SK, Buchanan GR, Adix L et al. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J. Pediatr. Hematol. Oncol. 2003; 25: 130-3.
3. Kûhne T, Buchanan GR, Zimmerman S et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from The Intercontinental Childhood ITP Study Group. J. Pediatr. 2003; 143: 605-8.
4. Lilleyman JS. Management of childhood idiopathic thrombocytopenic purpura. Br. J. Haematol. 1999; 105: 871-5.
5. George JN, Woolf SH, Raskob GE et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40.
6. Eden OB, Lilleyman JS. Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Arch. Dis. Child. 1992; 67: 1056-8.
7. Andrew M, Blanchette VS, Adams M et al. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J. Pediatr. 1992; 120: 522-7.
8. Lilleyman JS. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Arch. Dis. Child. 1994; 71: 251-3.
9. Buchanan GR, Adix L. Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura. Semin. Thromb. Hemost. 2001; 27: 277-85.
10. Medeiros D, Buchanan GR. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood. Pediatr. Clin. North Am. 1996; 43: 757-72.
11. Lilleyman J. Medical nemesis and childhood ITP. Br. J. Haematol. 2003; 123: 586-9.
12. Kûhne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 2001; 358: 2122-5.